Takeda Pharmaceutical Company Limited (TAK) Stock Price, News & Chart

	TAK	MOREPENLAB.NS	INDSWFTLAB.BO	STAR.NS	4547.T	4534.T
Market cap	67.28B	53.21B	31.50B	92.87B	161.53B	119.24B
P/E (TTM)	300.9	28.3	37.0	15.1	14.4	13.1
Forward P/E	39.7	—	—	11.7	17.6	18.1
Price/book	1.4	3.9	2.1	2.7	0.7	0.9
Dividend yield	2.93%	0.20%	—	0.49%	3.46%	2.60%
1-year change	+54.40%	+113.46%	+268.15%	+7.74%	−6.36%	+7.91%
Today	+1.49%	−4.17%	−4.09%	−0.65%	+3.06%	+3.66%

Market cap

67.28B

53.21B

31.50B

92.87B

161.53B

119.24B

P/E (TTM)

300.9

28.3

37.0

15.1

14.4

13.1

Forward P/E

39.7

—

11.7

17.6

18.1

Price/book

1.4

3.9

2.1

2.7

0.7

0.9

Dividend yield

2.93%

0.20%

—

0.49%

3.46%

2.60%

1-year change

+54.40%

+113.46%

+268.15%

+7.74%

−6.36%

+7.91%

Today

+1.49%

−4.17%

−4.09%

−0.65%

+3.06%

+3.66%

Company	Mkt cap	Price	Today
Morepen Laboratories LimitedMOREPENLAB.NS · Drug Manufacturers - Specialty & Generic	53.21B	97.10	−4.17%
Ind-Swift Laboratories LimitedINDSWFTLAB.BO · Drug Manufacturers - Specialty & Generic	31.50B	356.45	−4.09%
Strides Pharma Science LimitedSTAR.NS · Drug Manufacturers - Specialty & Generic	92.87B	1,007.60	−0.65%
Kissei Pharmaceutical Co., Ltd.4547.T · Drug Manufacturers - Specialty & Generic	161.53B	3,870.00	+3.06%
Mochida Pharmaceutical Co., Ltd.4534.T · Drug Manufacturers - Specialty & Generic	119.24B	3,395.00	+3.66%
Teva Pharmaceutical Industries LimitedTEVA · Drug Manufacturers - Specialty & Generic	48.81B	41.85	−0.14%
Towa Pharmaceutical Co., Ltd.4553.T · Drug Manufacturers - Specialty & Generic	179.68B	3,650.00	+3.84%
Windlas Biotech LimitedWINDLAS.NS · Drug Manufacturers - Specialty & Generic	19.01B	921.25	+5.47%

Company	Mkt cap	Price	Today
Bliss GVS Pharma LimitedBLISSGVS.NS · Mumbai, India	67.28B	632.45	+2.08%
Merck KGaAMRK.F · Darmstadt, Germany	65.87B	151.50	+0.50%
Ildong Holdings Co., Ltd.000230.KS · Seoul, South Korea	65.20B	5,650.00	+0.89%
KYORIN Pharmaceutical Co., Ltd.4569.T · Tokyo, Japan	66.01B	1,149.00	+4.64%
Sinil Pharmaceutical Co., Ltd.012790.KQ · Chungju-si, South Korea	72.48B	6,270.00	0.00%
FDC LimitedFDC.NS · Mumbai, India	63.85B	392.20	+0.32%
Aspen Pharmacare Holdings LimitedAPN.JO · Durban, South Africa	72.80B	16,816.00	+2.69%
Kukje Pharma Co., Ltd.002720.KS · Seongnam-si, South Korea	70.36B	3,325.00	−1.63%

Company	Mkt cap	Price	Today
Bliss GVS Pharma LimitedBLISSGVS.NS · Drug Manufacturers - Specialty & Generic	67.28B	632.45	+2.08%
Boston Scientific CorporationBSX · Medical Devices	66.41B	45.82	+5.33%
Access Bio, Inc.950130.KQ · Diagnostics & Research	64.19B	1,825.00	−3.95%
EssilorLuxottica Société anonyme1EL.MI · Medical Instruments & Supplies	65.75B	143.45	−1.00%
Merck KGaAMRK.F · Drug Manufacturers - Specialty & Generic	65.87B	151.50	+0.50%
Supriya Lifescience LimitedSUPRIYA.NS · Biotechnology	69.99B	869.60	+1.13%
Cencora, Inc.COR · Medical Distribution	67.55B	354.00	+3.96%
PharmGen Science, Inc.004720.KS · Drug Manufacturers - General	65.35B	2,890.00	+0.87%

Company	Mkt cap	Price	Today
Chugai Pharmaceutical Co., Ltd.CUP.F · Chuo, Japan	65.86B	40.02	+4.33%
Daiichi Sankyo Company, LimitedD4S.F · Chuo, Japan	31.06B	17.05	+5.64%
Sumitomo Electric Industries, Ltd.5802.T · Chuo, Japan	4.47T	1,431.00	−7.23%
Bridgestone Corporation5108.T · Chuo, Japan	5.25T	4,256.00	+6.13%
Astellas Pharma Inc.4503.T · Chuo, Japan	4.79T	2,672.50	+6.88%
Mitsui Fudosan Co., Ltd.8801.T · Chuo, Japan	4.68T	1,737.50	+6.27%
SMC Corporation6273.T · Chuo, Japan	3.69T	59,130.00	−4.17%
Konami Group CorporationKNM.L · Chuo, Japan	3.89T	28,660.00	+19.37%

Company	Mkt cap	Price	Today
Ipca Laboratories LimitedIPCALAB.NS · life sciences	494.62B	1,949.60	−1.14%
Yuyu Pharma, Inc.000220.KS · life sciences	58.66B	3,725.00	+0.40%
Dr. Reddy's Laboratories LimitedRDDA.F · life sciences	10.75B	12.90	+2.38%
Glenmark Pharmaceuticals LimitedGLENMARK.BO · life sciences	701.47B	2,485.50	−0.65%
Aurobindo Pharma LimitedAUROPHARMA.BO · life sciences	1.04T	1,788.30	+5.13%
Gufic Biosciences LimitedGUFICBIO.NS · life sciences	43.57B	434.45	+1.29%
Korea United Pharm Inc.033270.KS · life sciences	254.57B	16,050.00	+1.20%
Daewoong Pharmaceutical Co., Ltd069620.KS · life sciences	1.23T	106,700.00	+3.69%

Company	Mkt cap	Price	Today
SanofiSNY · Correlation 0.44	113.74B	47.47	+4.72%
Roche Holding AGRHHBY · Correlation 0.41	388.44B	60.94	+2.97%
KYORIN Pharmaceutical Co., Ltd.4569.T · Correlation 0.35	66.01B	1,149.00	+4.64%
Mochida Pharmaceutical Co., Ltd.4534.T · Correlation 0.31	119.24B	3,395.00	+3.66%

Company	Mkt cap	Price	Today
Vir Biotechnology, Inc.VIR	1.99B	11.77	+4.90%
Roche Holding LtdRHHBY	388.44B	60.94	+2.97%
SanofiSNY	113.74B	47.47	+4.72%
Arcturus Therapeutics HoldingsARCT	308.96M	10.87	+13.94%
Fate Therapeutics, Inc.FATE	250.42M	2.0900	+2.45%

Seeking Alpha·6d agoNegative

Takeda Pharmaceutical's Earnings Growth Has Yet To Translate To Higher Cash Flow

Takeda Pharmaceutical is reiterated as a hold, with concerns about its ability to replace major drug revenues and current valuation. Read more on TAK stock here. - Takeda Pharmaceutical is reiterated as a Hold, with concerns about its…

TAK BMY NVDA SPCX

The Globe and Mail·6d agoNegative

Bernstein Keeps Their Hold Rating on Takeda Pharmaceutical Co (TKPHF)

In a report released on January 16, Miki Sogi from Bernstein maintained a Hold rating on Takeda Pharmaceutical Co, with a price target of Yen4,700.00. The company’s shares closed last Tuesday at Yen5,073.00. Sogi covers the Healthcare…

USFD AZN JPM DB

MarketScreener·6d agoPositive

Takeda Pharmaceutical Raises Annual Guidance

Published on 10/29/2026 at 03:28 am EDT - Modified on 10/29/2026 at 03:29 am EDT Takeda Pharmaceutical raised its annual earnings forecasts, after swinging to a net profit in the second quarter. The Japanese drugmaker on Thursday reported…

LLY NVO TAK JNJ

Markets Daily·5d agoPositive

Takeda Pharmaceutical (NYSE:TAK) Posts Earnings Results, Beats Expectations By $0.37 EPS

Posted by Danessa Lincoln on Oct 30th, 2026 Takeda Pharmaceutical (NYSE:TAK – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.14 by…

TAK LLY BMY

MarketScreener·6d agoPositive

Takeda Pharmaceutical Eyes 2027 Japan Filing for Gastric Cancer Treatment

Takeda Pharmaceutical is targeting 2027 to file for regulatory approval in Japan for its experimental gastric cancer drug, arcotatug tavatecan, following positive results from a phase 3 clinical... Takeda Pharmaceutical Company Limited…

AZN

Seeking Alpha·6d agoNegative

Takeda outlines JPY 1.19T FY 2026 core operating profit forecast while targeting early November U.S. ORZEYFUL launch

Takeda Q2 FY2026 earnings: raised profit outlook, ORZEYFUL U.S. launch nears, and zaso UC data faces scrutiny. Earnings Call Insights: Takeda Pharmaceutical Company Limited (TAK) Q2 FY 2026 - CEO Julie Kim said, “In the first half, core…

TTWO TAK

Seeking Alpha·6d ago

Takeda Pharmaceutical Company Limited 2026 Q2 - Results - Earnings Call Presentation

2026-10-30. The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with their 2026 Q2 earnings call. The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction…

NVDA ABOS TAK PHAT

Markets Daily·Oct 27Positive

Takeda Pharmaceutical (TAK) Expected to Announce Earnings on Thursday

Posted by Danessa Lincoln on Oct 27th, 2026 Check Out Our Latest Research Report on TAK Takeda’s portfolio includes treatments such as Entyvio for inflammatory bowel disease, Takhzyro for hereditary angioedema, and medicines for certain…

TAK LLY ALKS

24/7 Wall St.·Oct 15Positive

Takeda Pharmaceutical TAK Clears Its 52-Week High at $19.45

As seen on the 24/7 Wall St. homepage on October 15, 2026. Takeda Pharmaceutical touched $19.45, a fresh 52-week high that clears the September 17 peak by 2.1%. The ADR and the OTC line are both at the top of their range. Takeda…

TAK LLY JNJ PFE

MarketScreener·Oct 15Positive

Takeda Pharmaceutical Company Limited Presents Phase 2/3 IgGNITE Study Results Of Investigational Subcutaneous TAK-881 In Primary Immunodeficiency Disease At ESID 2026

Published on 10/14/2026 at 09:37 am EDT 11.9 g/L) were above accepted protective thresholds against infections. Delivering equivalent bodyweight-adjusted IG dosing in a concentrated 20% solution reduced total infusion volume by 50%. This…

GILD

Days on the list

30 d

1 yr

Best

Gainers

#11

Losers

—

Gainers + losers

Most active

—

Most widely held

—

Trending

—

Install

Takeda Pharmaceutical Company Limited

Key statistics

Against its peers

Latest news